skip to main content
Show Results with:

Results 1 - 10 of 11  for Everything in this catalogue

results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies

Ward, Natalie C.; Page, Michael M.; Watts, Gerald F.

Diabetes, obesity & metabolism. Volume 21: (2019) Supplement 1; pp 52-62 -- [John Wiley & Sons Ltd]

Online access

2
Material Type:
Article
Add to My workspace

Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies

Ward, Natalie C.; Page, Michael M.; Watts, Gerald F.

Diabetes, obesity & metabolism. Volume 21 (2019) Supplement 1; pp 52-62 -- [John Wiley & Sons Ltd]

Online access

3
Material Type:
Article
Add to My workspace

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, Nick S. R. et al.

Diabetes, obesity & metabolism. Volume 21:Issue 7 (2019); pp 1734-1736 -- [John Wiley & Sons Ltd]

Online access

4
Material Type:
Article
Add to My workspace

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, Nick S. R. et al.

Diabetes, obesity & metabolism. Volume 21:Issue 7 (2019); pp 1734-1736 -- [John Wiley & Sons Ltd]

Online access

5
Material Type:
Article
Add to My workspace

PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

Page, Michael M.; Watts, Gerald F.

Diabetes, obesity & metabolism. Volume 20:Issue 2 (2018); pp 270-282 -- [John Wiley & Sons Ltd]

Online access

6
Material Type:
Article
Add to My workspace

PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

Page, Michael M.; Watts, Gerald F.

Diabetes, obesity & metabolism. Volume 20:Issue 2 (2018); pp 270-282 -- [John Wiley & Sons Ltd]

Online access

7
Material Type:
Article
Add to My workspace

Effect of niacin on triglyceride‐rich lipoprotein apolipoprotein B‐48 kinetics in statin‐treated patients with type 2 diabetes

Pang, J. et al.

Diabetes, obesity & metabolism. Volume 18:Issue 4 (2016); pp 384-391 -- [John Wiley & Sons Ltd]

Online access

8
Material Type:
Article
Add to My workspace

Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta‐analysis of clinical trials

Sahebkar, A. et al.

Diabetes, obesity & metabolism. Volume 17:Issue 11 (2015, November); pp 1042-1055 -- [John Wiley & Sons Ltd]

Online access

9
Material Type:
Article
Add to My workspace

Role of selective peroxisome proliferator‐activated receptor modulators in managing cardiometabolic disease: tale of a roller‐coaster

Sahebkar, A.; Watts, G. F.

Diabetes, obesity & metabolism. Volume 16:Issue 9 (2014, September); pp 780-792 -- [John Wiley & Sons Ltd]

Online access

10
Material Type:
Article
Add to My workspace

Atorvastatin plus omega‐3 fatty acid ethyl ester decreases very‐low‐density lipoprotein triglyceride production in insulin resistant obese men

Ng, T. W. K. et al.

Diabetes, obesity & metabolism. Volume 16:Issue 6 (2014, June); pp 519-526 -- [John Wiley & Sons Ltd]

Online access

Results 1 - 10 of 11  for Everything in this catalogue

results 1 2 next page

Searching Remote Databases, Please Wait